|
|
Article: Ranbaxy Laboratories Limited Selected to Present Metformin Research at the American Association Of Clinical Endocrinologists (AACE) 2004 Annual Meeting; Ranbaxy's Poster Presentation to Demonstrate Bioavailability of Metformin Under Fasting and Meal Conditions in Healthy Adults.
- Article from:
- PR Newswire
- Article date:
- April 30, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JACKSONVILLE, Fla., April 30 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc., (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has been selected to present its poster presentation, "An Assessment of the Pharmacokinetic Profile of Metformin Hydrochloride Oral Solution (100 mg/mL) (MOS) under Fasting, Low-Fat, and High Fat Meal Conditions," at the American Association of Clinical Endocrinologists' (AACE) 13th Annual Meeting and Clinical Congress on April 30, 2004. Ranbaxy's research shows no diminution of bioavailability of metformin in adults under either condition.
The study was conducted as an open-label, single-dose study comparing the ...